← 홈

고형암 (전체)

911개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 911개
ADCBiologicstaleNEOK Bio, Inc.Phase 1

NEOK002 RDE (NEOK002 RDE)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleHangzhou Cancer HospitalPhase 1

NK Cell adaptive transfer (NK Cell adaptive transfer)

Advanced Cancer; ADCC · Advanced Cancer

#AdvancedCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleGuangzhou Xiling Biotechnology …Phase 1

NK cell preparation (NK cell preparation)

Advanced Solid Tumors (Phase 1) · Advanced Solid Tumors (Phase 1)

#AdvancedSolidTumorsPhase1#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleZhejiang UniversityPhase 1

NKG2D CAR NK and NKG2D CAR T cells (NKG2D CAR NK and NKG2D CAR T cells)

Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments · Patients With Advanced Solid Tumors With

#PatientsWithAdvancedSolidTumorsW#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleZhejiang Provincial People's Ho…Phase 2

NKG2D CAR-NK with PD-1 Antibody (NKG2D CAR-NK with PD-1 Antibody)

Anaplastic Throid Carcinoma · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of ChicagoPhase 2

NY-ESO-1 TCR/ dnTGFβRII (NY-ESO-1 TCR/ dnTGFβRII)

Ovarian Cancer; Advanced Malignant Solid Tumor · Ovarian Cancer

#OvarianCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleOncomatryx Biopharma S.L.Phase 1

Nab-paclitaxel + Gemcitabine (Nab-paclitaxel + Gemcitabine)

Pancreatic Adenocarcinoma Metastatic · Pancreatic Adenocarcinoma Metastatic

#PancreaticAdenocarcinomaMetastat#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleWeill Medical College of Cornel…Phase 1

Naptumomab Estafenatox (Naptumomab Estafenatox)

Urothelial Carcinoma · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
CGTBiologicstalePACT Pharma, Inc.Phase 1

NeoTCR-P1 adoptive cell therapy (NeoTCR-P1 adoptive cell therapy)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED
AntibodystaleSeoul National University Hospi…Preclinical

atezolizumab (Tecentriq, Neoadjuvant atezolizumab)

Urothelial Carcinoma · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 2

Neoadjuvant ipilimumab (Neoadjuvant ipilimumab)

Renal Cell Carcinoma · Renal Cell Carcinoma

#RenalCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleThe Netherlands Cancer InstitutePhase 2

nivolumab (Opdivo, Neoadjuvant nivolumab)

Renal Cell Carcinoma · Renal Cell Carcinoma

#RenalCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleThe Netherlands Cancer InstitutePhase 2

Neoadjuvant relatlimab (Neoadjuvant relatlimab)

Renal Cell Carcinoma · Renal Cell Carcinoma

#RenalCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Nivolumab + Paclitaxel)

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma · Recurrent/Metastatic Head and Neck Squam

#RecurrentMetastaticHeadandNeckSq#Antibody#Phase2#항체#면역항체+4
효능 ORR 41.6%임상시험 1상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 3

nivolumab (Opdivo, Nivolumab + Relatlimab FDC)

Colorectal Neoplasms · Solid Tumors

#SolidTumors#Antibody#Phase3#항체#면역항체+3
효능 ORR 61.9%임상시험 1상태 DISCONTINUED
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Nivolumab and Nal-IRI/5-FU/LV - Expansion)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 3

nivolumab (Opdivo, Nivolumab and Recombinant Human Hyaluronidase)

Advanced Clear Cell Renal Cell Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma · Advanced Clear Cell Renal Cell Carcinoma

#AdvancedClearCellRenalCellCarcin#Antibody#Phase3#항체#면역항체+3
효능 ORR 0%임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPreclinical

pembrolizumab (Keytruda, Nivolumab or Pembrolizumab)

Lung Squamous Cell Carcinoma Stage IV · Lung Squamous Cell Carcinoma Stage IV

#LungSquamousCellCarcinomaStageIV#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Nivolumab, Nab paclitaxel and Gemcitabine - Expansion)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, Nivolumab, Pembrolizumab)

Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+2
효능 ORR 6%임상시험 1상태 ACTIVE

35 / 46 페이지

← 이전다음 →